433 related articles for article (PubMed ID: 35491743)
1. Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England.
Jackson SE; Cox S; Shahab L; Brown J
Addiction; 2022 Sep; 117(9):2504-2514. PubMed ID: 35491743
[TBL] [Abstract][Full Text] [Related]
2. Moderators of real-world effectiveness of smoking cessation aids: a population study.
Jackson SE; Kotz D; West R; Brown J
Addiction; 2019 Sep; 114(9):1627-1638. PubMed ID: 31117151
[TBL] [Abstract][Full Text] [Related]
3. Real-world effectiveness of smoking cessation aids: A population survey in England with 12-month follow-up, 2015-2020.
Jackson SE; Kock L; Kotz D; Brown J
Addict Behav; 2022 Dec; 135():107442. PubMed ID: 35908322
[TBL] [Abstract][Full Text] [Related]
4. 'Real-world' effectiveness of smoking cessation treatments: a population study.
Kotz D; Brown J; West R
Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
[TBL] [Abstract][Full Text] [Related]
5. Association of the COVID-19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019-20 data.
Jackson SE; Garnett C; Shahab L; Oldham M; Brown J
Addiction; 2021 May; 116(5):1233-1244. PubMed ID: 33089562
[TBL] [Abstract][Full Text] [Related]
6. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study.
Brown J; Beard E; Kotz D; Michie S; West R
Addiction; 2014 Sep; 109(9):1531-40. PubMed ID: 24846453
[TBL] [Abstract][Full Text] [Related]
7. Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends.
Beard E; West R; Michie S; Brown J
BMJ; 2016 Sep; 354():i4645. PubMed ID: 27624188
[TBL] [Abstract][Full Text] [Related]
8. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
9. COVID-19, smoking, vaping and quitting: a representative population survey in England.
Tattan-Birch H; Perski O; Jackson S; Shahab L; West R; Brown J
Addiction; 2021 May; 116(5):1186-1195. PubMed ID: 32918300
[TBL] [Abstract][Full Text] [Related]
10. Associations of Prevalence of E-cigarette Use With Quit Attempts, Quit Success, Use of Smoking Cessation Medication, and the Overall Quit Rate Among Smokers in England: A Time-Series Analysis of Population Trends 2007-2022.
Jackson SE; Brown J; Beard E
Nicotine Tob Res; 2024 Jun; 26(7):826-834. PubMed ID: 38214664
[TBL] [Abstract][Full Text] [Related]
11. Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study.
Ferguson SG; Brown J; Frandsen M; West R
Addiction; 2015 Mar; 110(3):513-8. PubMed ID: 25393225
[TBL] [Abstract][Full Text] [Related]
12. Is dual use of nicotine products and cigarettes associated with smoking reduction and cessation behaviours? A prospective study in England.
Jackson SE; Farrow E; Brown J; Shahab L
BMJ Open; 2020 Mar; 10(3):e036055. PubMed ID: 32179563
[TBL] [Abstract][Full Text] [Related]
13. Interventions to reduce harm from continued tobacco use.
Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the use of aids to cessation in English smokers.
Kotz D; Fidler J; West R
Addiction; 2009 Aug; 104(8):1403-10. PubMed ID: 19549267
[TBL] [Abstract][Full Text] [Related]
15. Self-Reported Quit Aids and Assistance Used By Smokers At Their Most Recent Quit Attempt: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey.
Gravely S; Cummings KM; Hammond D; Borland R; McNeill A; East KA; Loewen R; Martin N; Yong HH; Li L; Liber A; Levy DT; Quah ACK; Ouimet J; Hitchman SC; Thompson ME; Boudreau C; Fong GT
Nicotine Tob Res; 2021 Aug; 23(10):1699-1707. PubMed ID: 33837435
[TBL] [Abstract][Full Text] [Related]
16. Population-level predictors of changes in success rates of smoking quit attempts in England: a time series analysis.
Beard E; Jackson SE; West R; Kuipers MAG; Brown J
Addiction; 2020 Feb; 115(2):315-325. PubMed ID: 31626370
[TBL] [Abstract][Full Text] [Related]
17. Utilisation of smoking cessation aids among South African adult smokers: findings from a national survey of 18 208 South African adults.
Agaku I; Egbe C; Ayo-Yusuf O
Fam Med Community Health; 2021 Jan; 9(1):. PubMed ID: 33431587
[TBL] [Abstract][Full Text] [Related]
18. Have there been sustained impacts of the COVID-19 pandemic on trends in smoking prevalence, uptake, quitting, use of treatment, and relapse? A monthly population study in England, 2017-2022.
Jackson SE; Tattan-Birch H; Shahab L; Beard E; Brown J
BMC Med; 2023 Dec; 21(1):474. PubMed ID: 38093317
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of receipt by smokers of general practitioner advice on smoking cessation in England: a cross-sectional survey of adults.
Jackson SE; Garnett C; Brown J
Addiction; 2021 Feb; 116(2):358-372. PubMed ID: 32648976
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
